• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » The Story of Clozapine

The Story of Clozapine

February 1, 2005
From The Carlat Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

We may think of clozapine as a drug of the ‘90s, but Sandoz began research on the drug in the early ‘60s, and the first paper appeared in 1966, the Medical Journal of Vienna. A group of German psychiatrists presented positive findings from a multicenter trial of clozapine at about the same time, and the drug was introduced in Europe in 1972, the delay apparently because people were skeptical about an antipsychotic without extrapyramidal side effects. It seems that concerns about hypotension and seizures kept the drug from being introduced in North America at that time. In September 1975, The Lancet published a report from Finland of 18 cases of agranulocytosis, eight of them fatal, which ultimately led to the drug’s being taken off the market. It was reintroduced in Europe in the late ‘80s, and by 1990 it was available in the U.S., with mandatory blood tests to monitor for agranulocytosis. The term "atypical" was initially used to connote clozapine’s lack of extrapyramidal effects, but when receptor studies were introduced, it was soon shown that clozapine has an affinity for different receptor subtypes than the "typical" antipsychotics. This soon led to the "rational" drug design that has given us a smorgasbord of atypical (or second-generation, or new-generation) antipsychotics, each targeting a somewhat different set of receptors.

Source: Can J Psychiatry 1997; 42:152-162
General Psychiatry
    www.thecarlatreport.com
    Issue Date: February 1, 2005
    SUBSCRIBE NOW
    Table Of Contents
    The Story of Clozapine
    Atypicals for Bipolar: And Then There Were Five
    Philip G. Janicak, M.D. On Using Atypical Antipsychotics
    Clozapine: Is it truly better than the rest?
    Metabolic Side Effects: Here We Go Again!
    DOWNLOAD NOW
    Featured Book
    • MFB7e_Print_App_Access.png

      Medication Fact Book for Psychiatric Practice, Seventh Edition (2024) - Regular Bound Book

      The updated 2024 reference guide covering the most commonly prescribed medications in psychiatry.
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2622607431.jpg
      General Psychiatry

      Should You Test MTHFR?

      MTHFR is a...
      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.